Breaking News Instant updates and real-time market news.

2020-10-12 09:45:02 09:45 10/12/20 10/12 09:45 10/12/20 09:45	U.S. Week Ahead U.S. Week Ahead: It's an important week of data, however, and includes several key reports that should reveal further encouraging news on the recovery. The strength seen so far in July and August data suggest about a 33% rebound in Q3 GDP. As for this week's releases there's retail sales, industrial production, regional manufacturing PMIs, consumer sentiment, and CPI. The Q3 earnings season begins this week, leaving a busy slate of results from large cap firms. There's another heavy dose of Fedspeak. They've all expressed support for the new framework, though there have been some differences with respect to the degree of concerns over the economy and the recovery. Attention will be on comments from VC Clarida (Wednesday) who will speak on the economic outlook and from VC Quarles who will discuss financial stability (Wednesday) and the response to COVID-19 (Thursday). Also on the calendar are Barkin, Daly, Kaplan, Bostic, Kashkari, and Williams.

2020-10-12 09:45:02

09:45

10/12/20

10/12

09:45

10/12/20

09:45

U.S. Week Ahead

U.S. Week Ahead: It's an important week of data, however, and includes several key reports that should reveal further encouraging news on the recovery. The strength seen so far in July and August data suggest about a 33% rebound in Q3 GDP. As for this week's releases there's retail sales, industrial production, regional manufacturing PMIs, consumer sentiment, and CPI. The Q3 earnings season begins this week, leaving a busy slate of results from large cap firms. There's another heavy dose of Fedspeak. They've all expressed support for the new framework, though there have been some differences with respect to the degree of concerns over the economy and the recovery. Attention will be on comments from VC Clarida (Wednesday) who will speak on the economic outlook and from VC Quarles who will discuss financial stability (Wednesday) and the response to COVID-19 (Thursday). Also on the calendar are Barkin, Daly, Kaplan, Bostic, Kashkari, and Williams.

TODAY'S FREE FLY STORIES

Recommendations	Westlake Chemical price target raised to $98 from $92 at JPMorgan » 07:26 03/08/21 03/08 07:26 03/08/21 07:26 WLK Westlake Chemical $89.41 / +4.315 (+5.07%) JPMorgan analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly WLK Westlake Chemical $89.41 / +4.315 (+5.07%) 11/18/20 Westlake Chemical appoints Roger Kearns as COO, effective January 1 WLK Westlake Chemical $89.41 / +4.315 (+5.07%) 02/24/21 Wells Fargo Westlake Chemical price target raised to $104 from $95 at Wells Fargo 01/13/21 Deutsche Bank Westlake Chemical price target raised to $104 from $90 at Deutsche Bank 12/21/20 Fly Intel: Top five analyst upgrades 12/21/20 JPMorgan Westlake upgraded on 'snug' polyethylene market at JPMorgan WLK Westlake Chemical $89.41 / +4.315 (+5.07%) 02/23/21 Westlake Chemical Partners reports Q4 EPS 87c, consensus 73c 11/03/20 Westlake Chemical reports Q3 EPS 45c, consensus 46c WLK Westlake Chemical $89.41 / +4.315 (+5.07%) 10/09/20 GE reinstatement at Goldman among today's top calls on Wall Street
Hot Stocks	AirBoss of America to acquire BlackBox Biometrics for $27M » 07:26 03/08/21 03/08 07:26 03/08/21 07:26 ABSSF AirBoss of America $0.00 / + (+0.00%) AirBoss of America Corp.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ABSSF AirBoss of America $0.00 / + (+0.00%) 10/26/20 AirBoss of America acquires 100% ownership of Airboss Defense Group 10/05/20 AirBoss of America announces $22M in awards across ADG's survivability portfolio 09/28/20 AirBoss of America announces Husky long-term contract extension ABSSF AirBoss of America $0.00 / + (+0.00%) 01/21/21 Stifel AirBoss of America price target lowered to C$23.75 from C$33 at Stifel 01/20/21 CIBC AirBoss of America price target lowered to C$28 from C$31 at CIBC 01/14/21 Canaccord AirBoss of America price target lowered to C$27 from C$43 at Canaccord 12/18/20 TD Securities AirBoss of America price target lowered to C$29 from C$32 at TD Securities ABSSF AirBoss of America $0.00 / + (+0.00%) 01/19/21 AirBoss of America sees 2020 revenue $498M-$503M
Recommendations	LyondellBasell price target raised to $120 from $104 at JPMorgan » 07:25 03/08/21 03/08 07:25 03/08/21 07:25 LYB LyondellBasell $107.88 / +3.86 (+3.71%) JPMorgan analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly LYB LyondellBasell $107.88 / +3.86 (+3.71%) 02/17/21 Halliburton appoints Bob Patel to board of directors 01/26/21 LyondellBasell, Sinopec Shanghai sign agreement to form JV to produce PO and SM 12/07/20 LyondellBasell, SUEZ jointly announce the acquisition of TIVACO 10/02/20 LyondellBasell to acquire 50% of Sasol Louisiana assets for $2B in JV agreement LYB LyondellBasell $107.88 / +3.86 (+3.71%) 03/02/21 Fly Intel: Top five analyst upgrades 03/02/21 Wells Fargo LyondellBasell upgraded to Overweight from Equal Weight at Wells Fargo 03/01/21 Alembic Global LyondellBasell upgraded to Overweight from Neutral at Alembic Global 02/22/21 BofA LyondellBasell upgraded to Buy from Neutral at BofA LYB LyondellBasell $107.88 / +3.86 (+3.71%) 01/29/21 LyondellBasell reports Q4 ex-items EPS $2.19, consensus $1.36 10/30/20 LyondellBasell reports Q3 ex-items EPS $1.27, consensus $1.12 10/29/20 Notable companies reporting before tomorrow's open 10/29/20 Notable companies reporting before tomorrow's open LYB LyondellBasell $107.88 / +3.86 (+3.71%) 11/13/20 Disney upgrade among today's top calls on Wall Street
Downgrade	Mapletree Logistics Trust downgraded to Underweight from Overweight at JPMorgan » 07:23 03/08/21 03/08 07:23 03/08/21 07:23 MAPGF Mapletree Logistics Trust $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Initiation	Wedbush bullish on Nuvation Bio, initiates with an Outperform » 07:23 03/08/21 03/08 07:23 03/08/21 07:23 NUVB Nuvation Bio $10.86 / +0.36 (+3.43%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NUVB Nuvation Bio $10.86 / +0.36 (+3.43%) 06:29 Today Wedbush Nuvation Bio initiated with an Outperform at Wedbush 05:45 Today BTIG Nuvation Bio initiated with a Buy at BTIG 04:57 Today BMO Capital Nuvation Bio initiated with an Outperform at BMO Capital

Hot Stocks	Akoustis announces discharge of indentures related to convertible notes » 07:23 03/08/21 03/08 07:23 03/08/21 07:23 AKTS Akoustis $12.26 / -0.58 (-4.52%) Akoustis Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AKTS Akoustis $12.26 / -0.58 (-4.52%) 03/03/21 Akoustis awarded design win for XBAW filters from CBRS customer 02/01/21 Akoustis locks process flow for wafer-level-chip-scale-package 01/29/21 Akoustis receives volume order for XBAW WiFi 6E filter solutions 12/16/20 Akoustis receives first 5G mobile orders for XBAW filters AKTS Akoustis $12.26 / -0.58 (-4.52%) 02/23/21 Roth Capital Akoustis equity financing improves balance sheet, says Roth Capital 02/02/21 Lake Street Akoustis price target raised to $19 from $10 at Lake Street 02/01/21 Roth Capital Akoustis price target raised to $25 from $16 at Roth Capital 01/28/21 Oppenheimer Akoustis price target raised to $20 from $15 at Oppenheimer AKTS Akoustis $12.26 / -0.58 (-4.52%) 02/01/21 Akoustis reports Q2 EPS (30c), consensus (23c) 11/02/20 Akoustis reports Q4 non-GAAP EPS (23c), consensus (24c) 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference AKTS Akoustis $12.26 / -0.58 (-4.52%) 01/29/21 Akoustis options imply 10.9% move in share price post-earnings 01/07/21 Largest borrow rate increases among liquid names
Initiation	Viant initiated with a Buy at Needham » 07:23 03/08/21 03/08 07:23 03/08/21 07:23 DSP Viant $41.41 / -0.5 (-1.19%) Needham analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly DSP Viant $41.41 / -0.5 (-1.19%) 06:29 Today Needham Viant initiated with a Buy at Needham 06:28 Today JMP Securities Viant initiated with a Market Perform at JMP Securities 06:03 Today BofA Viant initiated with a Neutral at BofA 05:49 Today Canaccord Viant initiated with a Buy at Canaccord 10 Feb DSP Viant $41.41 / -0.5 (-1.19%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts
Downgrade	Mapletree Industrial Trust downgraded to Underweight from Overweight at JPMorgan » 07:22 03/08/21 03/08 07:22 03/08/21 07:22 MAPIF Mapletree Industrial Trust $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research MAPIF Mapletree Industrial Trust $0.00 / + (+0.00%) 01/11/21 HSBC Mapletree Industrial Trust upgraded to Buy from Hold at HSBC 04/28/20 Jefferies Mapletree Industrial Trust downgraded to Hold from Buy at Jefferies
Hot Stocks	Mateon Therapeutics completes enrollment for OT-101 study » 07:22 03/08/21 03/08 07:22 03/08/21 07:22 MATN Mateon Therapeutics $0.00 / + (+0.00%) Mateon Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News MATN Mateon Therapeutics $0.00 / + (+0.00%) 03/01/21 Mateon Therapeutics, Windlas publish PulmoHeal clinical data 02/22/21 Mateon Therapeutics, Windlas Biotech launch PulmoHeal in India 02/02/21 Mateon Therapeutics announces publication of ARTI-19 interim data 02/01/21 Mateon Therapeutics launches AI telemedicine platform for PMS
Upgrade	Mapletree Commercial Trust upgraded to Overweight from Neutral at JPMorgan » 07:22 03/08/21 03/08 07:22 03/08/21 07:22 MPCMF Mapletree Commercial Trust $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research MPCMF Mapletree Commercial Trust $0.00 / + (+0.00%) 01/11/21 HSBC Mapletree Commercial Trust downgraded to Hold from Buy at HSBC

Hot Stocks	Evolv Technology to be publicly traded through NewHold Investment Corp. merger » 07:21 03/08/21 03/08 07:21 03/08/21 07:21 NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) Evolv Technology and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) 07:01 Today NewHold Investment Corp (Class A Stock) trading halted, news dissemination 03/07/21 Fly Intel: Top five weekend stock stories NHIC NewHold Investment Corp. $10.00 / +0.03 (+0.30%) 03/07/21 Evolv going public in $1.7B SPAC merger, WSJ reports
Hot Stocks	Intersect ENT: CMS combines SINUVA sinus implant coverage under distinct code » 07:21 03/08/21 03/08 07:21 03/08/21 07:21 XENT Intersect ENT $23.77 / +0.8 (+3.48%) Intersect ENT announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events XENT Intersect ENT $23.77 / +0.8 (+3.48%) 11/17/20 Intersect ENT announces new leadership appointments 09/15/20 Intersect ENT agrees to acquire Fiagon AG Medical Technologies for EUR 60M 09/15/20 Intersect ENT agrees to acquire Fiagon AG Medical Technologies for EUR 60M 09/10/20 Intersect ENT signs Sinuva distribution agreement with AllianceRx Walgreens XENT Intersect ENT $23.77 / +0.8 (+3.48%) 01/15/21 Piper Sandler Intersect ENT price target raised to $23 from $17 at Piper Sandler 01/11/21 Canaccord Intersect ENT upgraded to Buy from Hold at Canaccord 11/19/20 BTIG Intersect ENT upgraded to Buy from Neutral at BTIG 11/02/20 Piper Sandler Intersect ENT price target raised to $17 from $16 at Piper Sandler XENT Intersect ENT $23.77 / +0.8 (+3.48%) 01/12/21 Intersect ENT reports preliminary Q4 revenue $27.7M-$28.1M, consensus $27.67M 11/02/20 Intersect ENT reports Q3 EPS (35c), consensus (45c) 10/15/20 Intersect ENT sees Q4 revenue about 85%-90% of Q4 in FY19 10/15/20 Intersect ENT sees Q3 revenue $22.4M-$22.8M, consensus $21.4M 03/09/21 Intersect ENT - XENT
Downgrade	Keppel DC REIT downgraded to Underweight from Overweight at JPMorgan » 07:21 03/08/21 03/08 07:21 03/08/21 07:21 KPDCF Keppel DC REIT $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Athira Pharma appoints Barbara Kosacz to board of directors » 07:20 03/08/21 03/08 07:20 03/08/21 07:20 ATHA Athira Pharma $19.13 / -0.13 (-0.67%) , KRON Kronos Bio $28.01 / -0.955 (-3.30%) Athira Pharma (ATHA)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ATHA KRON ATHA Athira Pharma $19.13 / -0.13 (-0.67%) 12/14/20 Athira says ATH platform can potentially address several clinical applications 12/14/20 LIFT-AD Phase 2/3, ACT-AD patient dosing among 2020 milestones, Athira says 12/14/20 Athira Pharma CEO says timelines 'remained on track' despite COVID 12/14/20 Urgent need remains for Alzheimer's treatment, Athira CEO says KRON Kronos Bio $28.01 / -0.955 (-3.30%) 03/04/21 Kronos Bio to initiate Phase 3 trial of entospletinib in mid-2021 02/25/21 Kronos Bio announces first patient dosed in Phase 1/2 KB-0742 trial 01/26/21 Kronos Bio appoints Marianne De Backer to board of directors 12/08/20 Kronos Bio appoints Pasit Phiasivongsa as SVP, pharmaceutical development ATHA KRON ATHA Athira Pharma $19.13 / -0.13 (-0.67%) 10/13/20 Jefferies Athira Pharma initiated with a Buy at Jefferies 10/13/20 JMP Securities Athira Pharma initiated with an Outperform at JMP Securities 10/13/20 Stifel Athira Pharma initiated with a Buy at Stifel 10/13/20 Goldman Sachs Athira Pharma initiated with a Buy at Goldman Sachs KRON Kronos Bio $28.01 / -0.955 (-3.30%) 11/03/20 Fly Intel: Top five analyst initiations 11/03/20 Jefferies Kronos Bio initiated with a Buy at Jefferies 11/03/20 Piper Sandler Kronos Bio initiated with an Overweight at Piper Sandler 11/03/20 Goldman Sachs Kronos Bio initiated with a Buy at Goldman Sachs ATHA KRON ATHA Athira Pharma $19.13 / -0.13 (-0.67%) 11/12/20 Athira Pharma reports Q EPS ($1.12), consensus (25c) KRON Kronos Bio $28.01 / -0.955 (-3.30%) 11/18/20 Kronos Bio reports Q3 EPS ($6.48), consensus ($1.47) 21 Jan 09 Oct 18 Sep ATHA KRON ATHA Athira Pharma $19.13 / -0.13 (-0.67%) 12/14/20 Meet Athira Pharma: A Fly exclusive interview with CEO Leen Kawas 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever KRON Kronos Bio $28.01 / -0.955 (-3.30%) 10/11/20 Opening Day: iHuman makes trading debut amid U.S.-China tensions KRON KRON Kronos Bio $28.01 / -0.955 (-3.30%) 01/28/21 new option listings on January 28th
Hot Stocks	Chemours announces project to reduce HFC-23 emissions at Kentucky site » 07:20 03/08/21 03/08 07:20 03/08/21 07:20 CC Chemours $27.43 / +1.32 (+5.06%) The Chemours Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options CC Chemours $27.43 / +1.32 (+5.06%) 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 01/22/21 DuPont, Corteva and Chemours resolve legal disputes from 2015 spin-off 12/14/20 Energy Fuels enters three-year monazite supply agreement with Chemours 11/03/20 Chemours says all sites remain operational CC Chemours $27.43 / +1.32 (+5.06%) 02/17/21 Citi Chemours price target raised to $29 from $27 at Citi 02/16/21 BMO Capital Chemours price target raised to $38 from $33 at BMO Capital 01/08/21 RBC Capital Chemours upgraded to Outperform from Sector Perform at RBC Capital 12/04/20 Barclays Chemours downgraded to Equal Weight ahead of PFAS news flow at Barclays CC Chemours $27.43 / +1.32 (+5.06%) 02/11/21 Chemours sees FY21 adjusted EPS $2.40-$3.12, consensus $2.60 02/11/21 Chemours reports Q4 adjusted EPS 61c, consensus 41c 11/03/20 Chemours reports Q3 adjusted EPS 47c, consensus 33c 11/03/20 Notable companies reporting after market close CC Chemours $27.43 / +1.32 (+5.06%) 11/03/20 Fly Intel: After-Hours Movers CC Chemours $27.43 / +1.32 (+5.06%) 02/02/21 Two new option listings on February 2nd 02/01/21 Three new option listings and five option delistings on February 1st 11/03/20 Chemours options imply 13.6% move in share price post-earnings

Downgrade	Frasers Centrepoint Trust downgraded to Neutral from Overweight at JPMorgan » 07:20 03/08/21 03/08 07:20 03/08/21 07:20 FRZCF Frasers Centrepoint Trust $0.00 / + (+0.00%) JPMorgan analyst Mervin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FRZCF Frasers Centrepoint Trust $0.00 / + (+0.00%) 05/21/20 JPMorgan Frasers Centrepoint Trust upgraded to Overweight from Neutral at JPMorgan
Earnings	United Bancshares reports 2020 EPS $4.21, up 95c vs. last year » 07:19 03/08/21 03/08 07:19 03/08/21 07:19 UBOH United Bancshares $23.60 / + (+0.00%) Return on average total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Gap price target raised to $31 from $26 at Deutsche Bank » 07:18 03/08/21 03/08 07:18 03/08/21 07:18 GPS Gap $27.30 / +1.87 (+7.35%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GPS Gap $27.30 / +1.87 (+7.35%) 03/04/21 Gap recorded $56M impairment charge in Q4 related to Intermix 03/04/21 Gap reports Q4 Old Navy Global SSS up 7% y/y 02/24/21 Gap to open distribution center in Longview, Texas 01/21/21 Gap's Athleta adds extended sizing to 350 styles in its 200 stores, online GPS Gap $27.30 / +1.87 (+7.35%) 03/05/21 B. Riley Securities Gap price target raised to $27 from $22 at B. Riley Securities 03/05/21 JPMorgan Gap price target raised to $32 from $30 at JPMorgan 03/05/21 Morgan Stanley Gap price target raised to $29 from $27 at Morgan Stanley 03/05/21 Baird Gap price target raised to $29 from $25 at Baird GPS Gap $27.30 / +1.87 (+7.35%) 03/04/21 Gap sees FY21 EPS $1.20-$1.35, consensus $1.28 03/04/21 Gap reports Q4 EPS 61c, consensus 18c 03/04/21 Notable companies reporting after market close 11/24/20 Gap reports Q3 Old Navy SSS up 17% y/y GPS Gap $27.30 / +1.87 (+7.35%) 03/05/21 Gap CEO sees 'peacocking effect' as people emerge from Covid, WSJ reports 02/28/21 Macy's, Gap letting customers buy now, pay later, WSJ reports 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports 10/20/20 Gap reviewing options for its Gap Europe business, Bloomberg says GPS Gap $27.30 / +1.87 (+7.35%) 03/04/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday GPS Gap $27.30 / +1.87 (+7.35%) 03/05/21 Early notable gainers among liquid option names on March 5th 02/02/21 Gap call volume above normal and directionally bullish 11/27/20 Notable open interest changes for November 27th 11/24/20 Gap options imply 9.2% move in share price post-earnings
Initiation	Adagene initiated with an Overweight at Morgan Stanley » 07:18 03/08/21 03/08 07:18 03/08/21 07:18 ADAG Adagene $23.05 / +0.39 (+1.72%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly ADAG Adagene $23.05 / +0.39 (+1.72%) 03/06/21 Goldman Sachs Adagene initiated with a Buy at Goldman Sachs 09 Feb ADAG Adagene $23.05 / +0.39 (+1.72%) 02/14/21 Opening Day: Bumble, Viant soar in market debuts
Recommendations	Playa show see cash flow inflection no later than Q4, says Deutsche Bank » 07:18 03/08/21 03/08 07:18 03/08/21 07:18 PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) 01/21/21 Davidson Kempner reports 8.46% passive stake in Playa Hotels & Resorts 11/16/20 Hilton La Romana reopens following temporary closure 11/04/20 Playa Hotels & Resorts to sell the Dreams Puerto Aventuras for $34.5M 10/08/20 Playa Hotels & Resorts resumes normal operations at Yucatan resorts PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) 01/11/21 Macquarie Playa Hotels & Resorts price target raised to $8 from $7 at Macquarie 12/15/20 Citi Playa Hotels & Resorts upgraded to Neutral from Sell at Citi 07/02/20 Citi Playa Hotels & Resorts price target raised to $3 from $1 at Citi 04/29/20 SunTrust Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) 03/04/21 Playa Hotels & Resorts reports Q4 EPS (55c), consensus (45c) 11/04/20 Playa Hotels & Resorts reports Q3 EPS (57c), consensus (45c) 07 Jan 19 Nov PLYA Playa Hotels & Resorts $6.85 / -0.05 (-0.72%) 03/04/21 Fly Intel: After-Hours Movers 01/06/21 Fly Intel: After-Hours Movers

Hot Stocks	Passage Bio to start PBFT02 clinical program in 1H21 » 07:18 03/08/21 03/08 07:18 03/08/21 07:18 PASG Passage Bio $19.83 / +0.44 (+2.27%) Passage Bio is advancing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PASG Passage Bio $19.83 / +0.44 (+2.27%) 07:17 Today Passage Bio to start Phase 1/2 trial of PBKR03 in 1H21 07:16 Today Passage Bio to dose first patient in global Imagine-1 study in Q1 07:15 Today Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 03/03/21 Passage Bio announces anticipated upcoming milestones PASG Passage Bio $19.83 / +0.44 (+2.27%) 05:06 Today Chardan Passage Bio price target raised to $45 from $35 at Chardan 03/04/21 Citi Citi remains buyer of Passage Bio into first clinical data 03/04/21 Goldman Sachs Passage Bio upgraded to Buy from Neutral at Goldman Sachs 02/04/21 Fly Intel: Top five analyst initiations PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.83 / +0.44 (+2.27%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday PASG Passage Bio $19.83 / +0.44 (+2.27%) 12/09/20 Nine new option listings on December 9th
Hot Stocks	Passage Bio to start Phase 1/2 trial of PBKR03 in 1H21 » 07:17 03/08/21 03/08 07:17 03/08/21 07:17 PASG Passage Bio $19.83 / +0.44 (+2.27%) Passage Bio is developing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PASG Passage Bio $19.83 / +0.44 (+2.27%) 07:16 Today Passage Bio to dose first patient in global Imagine-1 study in Q1 07:15 Today Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 03/03/21 Passage Bio announces anticipated upcoming milestones 02/19/21 Passage Bio appoints Maxine Gowen to board of directors PASG Passage Bio $19.83 / +0.44 (+2.27%) 05:06 Today Chardan Passage Bio price target raised to $45 from $35 at Chardan 03/04/21 Citi Citi remains buyer of Passage Bio into first clinical data 03/04/21 Goldman Sachs Passage Bio upgraded to Buy from Neutral at Goldman Sachs 02/04/21 Fly Intel: Top five analyst initiations PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.83 / +0.44 (+2.27%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday PASG Passage Bio $19.83 / +0.44 (+2.27%) 12/09/20 Nine new option listings on December 9th
Hot Stocks	Passage Bio to dose first patient in global Imagine-1 study in Q1 » 07:16 03/08/21 03/08 07:16 03/08/21 07:16 PASG Passage Bio $19.83 / +0.44 (+2.27%) PBGM01 is being studied… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PASG Passage Bio $19.83 / +0.44 (+2.27%) 07:15 Today Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 03/03/21 Passage Bio announces anticipated upcoming milestones 02/19/21 Passage Bio appoints Maxine Gowen to board of directors 02/08/21 Passage Bio's IND application for Krabbe disease candidate cleared by FDA PASG Passage Bio $19.83 / +0.44 (+2.27%) 05:06 Today Chardan Passage Bio price target raised to $45 from $35 at Chardan 03/04/21 Citi Citi remains buyer of Passage Bio into first clinical data 03/04/21 Goldman Sachs Passage Bio upgraded to Buy from Neutral at Goldman Sachs 02/04/21 Fly Intel: Top five analyst initiations PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.83 / +0.44 (+2.27%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday PASG Passage Bio $19.83 / +0.44 (+2.27%) 12/09/20 Nine new option listings on December 9th
Hot Stocks	Passage Bio receives Fast Track designations for PBGM01, PBFT02, PBKR03 » 07:15 03/08/21 03/08 07:15 03/08/21 07:15 PASG Passage Bio $19.83 / +0.44 (+2.27%) Passage Bio announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio announces anticipated upcoming milestones 02/19/21 Passage Bio appoints Maxine Gowen to board of directors 02/08/21 Passage Bio's IND application for Krabbe disease candidate cleared by FDA 01/28/21 Passage Bio annoounces FDA IND clearance for PBFT02 PASG Passage Bio $19.83 / +0.44 (+2.27%) 05:06 Today Chardan Passage Bio price target raised to $45 from $35 at Chardan 03/04/21 Citi Citi remains buyer of Passage Bio into first clinical data 03/04/21 Goldman Sachs Passage Bio upgraded to Buy from Neutral at Goldman Sachs 02/04/21 Fly Intel: Top five analyst initiations PASG Passage Bio $19.83 / +0.44 (+2.27%) 03/03/21 Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.83 / +0.44 (+2.27%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday PASG Passage Bio $19.83 / +0.44 (+2.27%) 12/09/20 Nine new option listings on December 9th
Hot Stocks	Victory Capital announces Alderwood secures FCA authorization » 07:15 03/08/21 03/08 07:15 03/08/21 07:15 VCTR Victory Capital $24.55 / +0.94 (+3.98%) Victory Capital reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options VCTR Victory Capital $24.55 / +0.94 (+3.98%) 02/10/21 Victory Capital reports AUM of $146.2B as of January 31 01/13/21 Victory Capital reports AUM $147.2B on December 31 01/13/21 Victory Capital reports AUM of $147.2B on December 31, 2020 12/10/20 Victory Capital reports November-end AUM of $142.5B vs. $131.1B prior month VCTR Victory Capital $24.55 / +0.94 (+3.98%) 11/19/20 Fly Intel: Top five analyst downgrades 11/19/20 BofA Victory Capital double-downgraded to Underperform from Buy at BofA 10/16/20 B. Riley Securities Victory Capital price target raised to $24 from $22 at B. Riley Securities 07/09/20 Barclays Victory Capital price target raised to $21 from $19 at Barclays VCTR Victory Capital $24.55 / +0.94 (+3.98%) 02/10/21 Victory Capital reports Q4 adjusted EPS $1.07, consensus $1.02 11/04/20 Victory Capital reports Q3 adjusted EPS $1.00, consensus 93c 05/13/21 Victory Capital VCTR Victory Capital $24.55 / +0.94 (+3.98%) 01/06/21 Fifteen new option listings on January 6th

Events

Earnings calls, analyst events, roadshows and more

XPEV
Today at 08:00

Xpeng - XPEV Conference Calls
NIU
Today at 08:00

Niu Technologies - NIU Conference Calls
NERV
Today at 08:30

Minerva - NERV Conference Calls
CI
Today at 08:30

CIGNA Corporation Firm Sponsored Meetings
ABCM
Today at 09:00

Abcam - ABCM Conference Calls
Today at 10:00

Wholesale Inventories (Preliminary) M/M: January 2021 Government Event
NINE
Today at 10:00

Nine Energy Service - NINE Conference Calls
MGIC
Today at 10:00

Magic Software - MGIC Conference Calls
FOLD
Today at 10:00

Amicus - FOLD Conference Calls
PERI
Today at 10:00

Perion Network Ltd. Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CPNG X CPNG Coupang IPO Managers: Goldman Sachs, Allen & Co., JPMorgan & BofA, HSBC, Deutsche Bank, UBS, MIZU, CLSA $27.00-30.00 120M Shares GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HAYW X HAYW Hayward IPO Managers: BofA, Goldman Sachs & Nomura, Credit Suisse, Morgan Stanley, Baird, Guggenheim, Jefferies, BMO Capital, KeyBanc, William Blair, HOUL, Moelis $17.00-19.00 40.278M Shares
Thurs	JOAN X JOAN Joann IPO Managers: BofA & Credit Suisse, Guggenheim, Barclays, Wells Fargo, Piper Sandler, William Blair, HOUL, Telsey Advisory, Loop Capital, Ramirez $15.00-17.00 10.94M Shares
Fri	No deals

View All Syndicate Announcements »

U.S. Week Ahead

TODAY'S FREE FLY STORIES

Get Full Fly Access